Treatment of chromoblastomycosis with terbinafine: A report of four cases

Abstract

This report is about four cases of chromoblastomycosis confirmed by direct examination, histopathology and cultures. The duration of disease infection varied from 5 to 12 years. By culture, Cladosporium carrionii was isolated in two cases and Fonsecaea pedrosoi in the other two cases. Terbinafine 0.25 g twice daily for 1 month and 0.25 g once daily for maintenance therapy were given to three patients. Terbinafine 0.25 g once daily was given to one patient. After 4–8 months of therapy, all cases were cured without relapse when followed up for 6 months. The total dosage of terbinafine was 37.5–60 g. No relevant side effects showed during treatment.

• Mycosis
• treatment
• skin disease